Australia markets open in 6 hours 4 minutes

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.0000-0.6300 (-11.19%)
At close: 04:00PM EDT
5.0098 +0.01 (+0.20%)
After hours: 07:32PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 310.04M
Enterprise value 270.15M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.57
Price/book (mrq)2.45
Enterprise value/revenue 1.38
Enterprise value/EBITDA -41.52

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3-81.41%
S&P500 52-week change 326.49%
52-week high 327.7000
52-week low 33.9200
50-day moving average 310.6478
200-day moving average 312.1860

Share statistics

Avg vol (3-month) 3964.2k
Avg vol (10-day) 34.01M
Shares outstanding 562.01M
Implied shares outstanding 665.53M
Float 843.53M
% held by insiders 127.45%
% held by institutions 168.42%
Shares short (30 Apr 2024) 43.04M
Short ratio (30 Apr 2024) 49.46
Short % of float (30 Apr 2024) 46.30%
Short % of shares outstanding (30 Apr 2024) 44.91%
Shares short (prior month 28 Mar 2024) 42.64M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -27.93%
Operating margin (ttm)-37.01%

Management effectiveness

Return on assets (ttm)-14.33%
Return on equity (ttm)-38.55%

Income statement

Revenue (ttm)196.03M
Revenue per share (ttm)3.18
Quarterly revenue growth (yoy)21.10%
Gross profit (ttm)N/A
EBITDA -50.54M
Net income avi to common (ttm)-54.75M
Diluted EPS (ttm)-0.8800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)110.01M
Total cash per share (mrq)1.77
Total debt (mrq)70.11M
Total debt/equity (mrq)55.47%
Current ratio (mrq)3.98
Book value per share (mrq)2.04

Cash flow statement

Operating cash flow (ttm)-24.54M
Levered free cash flow (ttm)-25.39M